Skip to main content
Clinical Trials/CTRI/2022/10/046546
CTRI/2022/10/046546
Not yet recruiting
Phase 3

To Determine The Efficacy Of Individualised Homoeopathic Medicines In Reducing Chronic Plantar Heel Pain- A Randomised Double-Blind Placebo Control Trial

Dr A Abhay Krishnan0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr A Abhay Krishnan
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr A Abhay Krishnan

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients presenting with symptoms of chronic plantar heel pain.
  • 2\. Patients in the age group of 18\-65 years of age.
  • 3\. Patient showing clinical or radiological evidence of plantar fasciitis or calcaneal spur.

Exclusion Criteria

  • 1\. Patients presenting with acute onset of heel pain (less than three weeks duration)
  • 2\. Patients presented with the worst possible pain on the VAS scale
  • 3\. Patients showing positive R.A. factor and CRP during the investigation
  • 4\. Presenting with any fracture or tumour confirmed by radiological evidence
  • 5\. Pregnant or breastfeeding women
  • 6\. Have received a corticosteroid injection in the foot during the preceding six months.

Outcomes

Primary Outcomes

Not specified

Similar Trials